HCM (Hutchison MediPharma) Multiplikator nilai perusahaan marang pendapatan

Logo perusahaan publik hutch-med.com (HCM)

HUTCHMED (HCM) proprietary plants and R&D centers operate at maximum efficiency, implementing GMP standards for global export. The company's EV/Revenue ratio helps monitor this trend, while the 1962.76 indicator reflects the status of the current valuation. The holding combines the development of oncology drugs with distribution in China to ensure financial stability, delegating clinical trials and marketing to external contractors.

Hutchison MediPharma - Nilai perusahaan marang pendapatan HCM (periode 23.11.2025 - 20.11.2026)

hutch-med.com - rincian analitis lan metrik utama (HCM)

- nilai saham lan prakiraan konsensus rega:
Analisis wiwitan perusahaan:HUTCHMED (China) Limited HCM
Sampel barang HUTCHMED (China) Limited

The global commercialization of innovative drugs by HUTCHMED (HCM) relies on strategic partnerships, which directly impacts revenue growth rates. By analyzing the EV/Revenue multiple on GURU.Markets, an investor assesses the business value accounting for net debt to determine whether a low valuation results from fundamental stagnation or represents an entry point into an undervalued asset.

Analisis pesaing HUTCHMED (China) Limited

Multiplikator nilai perusahaan marang pendapatan Incyte Corporation|NUVB: Multiplikator EV/Sales|Rasio nilai perusahaan marang dodolan Day One Bio DAWN|Nilai perusahaan marang pendapatan MNPR|Multiplikator nilai perusahaan marang pendapatan Inhibrx Biosciences INBX|Nilai perusahaan marang pendapatan IMAB (I-Mab Biopharma Co., Ltd.)|FENC (Fennec Pharmaceuticals Inc.) - Nilai bisnis marang pendapatan|Heron Therapeutics, Inc. - Nilai perusahaan marang pendapatan|Koefisien nilai perusahaan marang pendapatan NVCT (Nuvectis Pharma)|Coherus BioSciences, Inc. - Multiplikator EV/Sales|Nilai bisnis marang pendapatan CRBP (Corbus Pharma)|CRDF: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan beyondspringpharma.com (BYSI)|Rasio nilai perusahaan marang pendapatan bioatla.com|LIXT: Nilai bisnis marang pendapatan|Multiplikator EV/Sales CTXR|Multiplikator EV/Sales Cellectar Corp (CLRB)|Rasio nilai perusahaan marang pendapatan BioLineRx Corp BLRX|CANF (Can-Fite BioPharma Ltd.) - Nilai perusahaan marang volume dodolan|APRE: Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Kazia Therapeutics Limited|Silexion Therapeutics Corp (SLXN) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan NCNA|CMRX (Chimerix, Inc.) - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Cyclacel Pharmaceuticals CYCC|G1 Therapeutics Inc. (GTHX) - Nilai bisnis marang pendapatan|KRON - Multiplikator nilai perusahaan marang pendapatan|Kintara Therapeutics, Inc. - Nilai perusahaan marang pendapatan|Koefisien nilai perusahaan marang pendapatan ONCT (Oncternal)|Portage Biotech Corp - Multiplikator EV/Sales